Pharma Douche Banned From Industry, Must Pay $65M

The Washington Post reports:

A federal judge on Friday ordered Martin Shkreli to return $64.6 million in profits he and his company reaped from inflating the price of the life-saving drug Daraprim and barred him from participating in the pharmaceutical industry for the rest of his life. The ruling by U.S. District Judge Denise Cote came several weeks after a seven-day bench trial in December. The Federal Trade Commission and seven states brought the case in 2020 against the man dubbed in the media as “Pharma Bro.”

Read the full article. Shkreli is serving a seven year prison sentence for unrelated hedge fund violations. In 2017, while awaiting sentencing that case, his bail was revoked after he tweeted an offer of a $5000 bounty for a strand of Hillary Clinton’s hair.